Vericel Corp (VCEL)

• Market cap: $2.1B
• 1 day: -0.56%
• 5 days: -4.05%
• 1 month: -12.33%
• 3 months: 19.6%
• 6 months: 15.81%
• Year to date: 15%
• 1 year: 14.1%
• 5 years: -26.45%
• 10 years: 1,650%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 398